title: Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells.
abstract: Increased cell migration and invasion lead to cancer metastasis and are crucial to cancer prognosis. In this study, we explore whether FBXW7 plays any role in metastatic process. We show that depletion of FBXW7 induces epithelial-mesenchymal transition (EMT) in human colon cancer cells along with the increase in cell migration and invasion. Moreover, FBXW7 deficiency promotes the generation of colon cancer stem-like cells in tumor-sphere culture. mTOR inhibition by rapamycin suppresses FBXW7 loss-driven EMT, invasion and stemness. Our results define the FBXW7/mTOR axis as a novel EMT pathway that mediates cancer invasion.
authors.affiliation: Department of Anatomy and Key Laboratory of Experimental Teratology, Ministry of Education, Shandong University School of Medicine, 44 Wenhuaxilu, Jinan, Shandong 250012, PR China.
authors.forename: Yuli
authors.initials: Y
authors.lastname: Wang
authors.forename: Yueyong
authors.initials: Y
authors.lastname: Liu
authors.forename: Jing
authors.initials: J
authors.lastname: Lu
authors.forename: Pengju
authors.initials: P
authors.lastname: Zhang
authors.forename: Yunshan
authors.initials: Y
authors.lastname: Wang
authors.forename: Yangyang
authors.initials: Y
authors.lastname: Xu
authors.forename: Zeran
authors.initials: Z
authors.lastname: Wang
authors.forename: Jian-Hua
authors.initials: JH
authors.lastname: Mao
authors.forename: Guangwei
authors.initials: G
authors.lastname: Wei
mesh_terms: D015153:Blotting, Western; D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism*; D002465:Cell Movement; D048430:Cell Shape; D015179:Colorectal Neoplasms / Q000378:metabolism / Q000473:pathology*; D058750:Epithelial-Mesenchymal Transition; D044783:F-Box Proteins / Q000235:genetics / Q000378:metabolism*; D000073979:F-Box-WD Repeat-Containing Protein 7; D015972:Gene Expression Regulation, Neoplastic; D045325:HCT116 Cells; D006801:Humans; D009361:Neoplasm Invasiveness / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000378:metabolism / Q000473:pathology; D020123:Sirolimus / Q000494:pharmacology*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors; D044767:Ubiquitin-Protein Ligases / Q000235:genetics / Q000378:metabolism*
chemical_list: D018797:Cell Cycle Proteins; D044783:F-Box Proteins; D000073979:F-Box-WD Repeat-Containing Protein 7; C513273:FBXW7 protein, human; D044767:Ubiquitin-Protein Ligases; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus
references.citation: Cancer Metastasis Rev. 2012 Jun;31(1-2):75-87
references.pmid: 22124735
references.citation: Nature. 2004 Mar 4;428(6978):77-81
references.pmid: 14999283
references.citation: Nat Rev Cancer. 2002 Jun;2(6):442-54
references.pmid: 12189386
references.citation: Cell. 2009 Nov 25;139(5):871-90
references.pmid: 19945376
references.citation: Oncogene. 2014 Jan 30;33(5):599-610
references.pmid: 23334326
references.citation: Nature. 2001 Nov 1;414(6859):105-11
references.pmid: 11689955
references.citation: Nat Commun. 2012;3:976
references.pmid: 22864569
references.citation: Aging (Albany NY). 2013 Feb;5(2):111-9
references.pmid: 23454868
references.citation: Cancer Res. 2011 May 1;71(9):3246-56
references.pmid: 21430067
references.citation: Cell. 2008 May 16;133(4):704-15
references.pmid: 18485877
references.citation: Clin Transl Med. 2013 Jan 17;2(1):3
references.pmid: 23369605
references.citation: Mol Cancer Res. 2012 May;10(5):588-96
references.pmid: 22522455
references.citation: Cancer Res. 2013 Jan 15;73(2):953-66
references.pmid: 23204235
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3338-45
references.pmid: 14766969
references.citation: Mol Cancer Res. 2012 Jun;10(6):834-44
references.pmid: 22513362
references.citation: Genes Cells. 2012 Sep;17(9):768-77
references.pmid: 22897623
references.citation: Nature. 2004 Dec 9;432(7018):775-9
references.pmid: 15592418
references.citation: Nat Rev Cancer. 2008 Feb;8(2):83-93
references.pmid: 18094723
references.citation: Nature. 2012 May 30;485(7400):S55-7
references.pmid: 22648500
references.citation: Science. 2008 Sep 12;321(5895):1499-502
references.pmid: 18787170
references.citation: J Biol Chem. 2004 Mar 5;279(10):9417-23
references.pmid: 14672936
references.citation: Nat Rev Cancer. 2009 Apr;9(4):265-73
references.pmid: 19262571
references.citation: PLoS One. 2012;7(8):e40938
references.pmid: 22912667